Scientific studies & consumer anecdotes about healthier living by reversing NAD+ decline (for information purposes only)

Category: Pre-Clinical Study

Recently Completed Pre-Clinical Trials Studying Nicotinamide Riboside

From yesterday’s Chromadex (sellers of Nicotinamide Riboside “NR” (FAQs) (Reviews)) earnings call:

Why Are There So Many Clinical Trials to Test Nicotinamide Riboside (NR) in People?

If you’re focused on maintaining your NAD levels, you should be aware that simply eating a healthy diet may not be enough. And since your NAD system can also be disturbed by inflammation, aging, and conditions of metabolic stress, there’s a case to be made for supplementation with Nicotinamide Riboside “NR” (FAQs) (Reviews). Dr. Charles Brenner (who discovered NR as an NAD precursor vitamin) made that case in a recent Twitter thread and also explained the abundance of ongoing clinical trials testing NR:

Can Boosting NAD Levels with Nicotinamide Riboside (NR) Protect Against Viruses?

Nutritional Outlook magazine just published an article entitled “Preclinical research shows that COVID-19 infection may dysregulate NAD+ synthesis”. Key excerpt:

Can Nicotinamide Riboside (NR) Reduce Hearing Loss?

A recent pre-clinical study showed that supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) reduced hearing loss in mice. The lead scientist on the study commented:

Powered by WordPress & Theme by Anders Norén